Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. - Wikidata - wikimedia - TriplyDB

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

http://www.wikidata.org/entity/Q37321697

about

Hormone therapy for preventing cardiovascular disease in post-menopausal women Hormone therapy for preventing cardiovascular disease in post-menopausal women Long term hormone therapy for perimenopausal and postmenopausal women Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes Window of opportunity: estrogen as a treatment for ischemic stroke The treatment of climacteric symptoms Menopausal hormone therapy and breast cancer mortality: clinical implications Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study Long-term hormone therapy for perimenopausal and postmenopausal women.Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer Comparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.Influence of sex hormones and phytoestrogens on heart disease in men and women Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy.Treatment of the menopause: the swinging pendulum.Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERα/ERβ balance in female mice.Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues.Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.The 2012 hormone therapy position statement of: The North American Menopause Society.Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Breast cancer risk in relation to the interval between menopause and starting hormone therapy.Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity G-protein coupled estrogen receptor, estrogen receptor α, and progesterone receptor immunohistochemistry in the hypothalamus of aging female rhesus macaques given long-term estradiol treatment.A meta-analysis of reference values of leptin concentration in healthy postmenopausal women.Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial.A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009 Potential age-dependent effects of estrogen on neural injury Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.Vascular Aging in Women: is Estrogen the Fountain of Youth?Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women.Estrogen signaling and cardiovascular disease.

P2860

Q24187326-27316A50-7726-416E-B13F-7539AEE423A7 Q24197712-5677FA64-2524-40EE-83F9-1DF814F879EB Q24201974-7965D581-8FA6-45C2-9B06-8D62DF482F62 Q24626206-EE056484-5BFE-4887-B8ED-175115F397D3 Q26828794-E4244CD1-0DDD-4373-A738-C69806779D66 Q26992273-17ABD1B8-EE65-4BD2-B997-90E07068D7F6 Q27022201-54B6791F-3EA2-43B5-852D-B370467706F6 Q28730966-2B5FCAF9-BEA9-4B33-8FF9-032D96096346 Q30238978-E361029A-16DF-4217-ACB6-2142AADF8904 Q30433883-947FED92-A12D-47BB-8079-854A5DBC467B Q30498819-6300C112-462E-4F9A-A4CC-F333216CCD59 Q30655662-B6EB2032-B2B1-4761-A82D-AD9CCB7E18DB Q30659580-AFC155BD-3C31-4B95-8003-489BD9D1393B Q30696956-1A235DF1-0EEF-426A-BC5C-52973D2A6704 Q33644735-45942813-0C38-4732-AE97-1E868C0E296F Q33681494-FA81F519-568A-4680-821C-6A655C3546D1 Q33721061-D35E8943-EDAE-4296-B63D-C3367498C889 Q33751046-AB4D107F-61CB-413D-9164-17A4E0043341 Q33876807-BE938416-B227-4EFD-B123-C28C99B3F42B Q34038237-70C5A546-BC9A-4F64-AC95-952166E086BA Q34051348-CAC1EF55-42AB-4F6E-897C-7AF5C9063A12 Q34116445-27F45DAB-F2FD-4846-9925-41DE589F60E7 Q34120300-F3698771-617F-4DFD-B9DD-3D129597744C Q34147730-8EA5F3F2-C9D5-4CC1-80E3-DC38628E5DB9 Q34161400-A664E349-735E-4497-9BCD-E282F03EA145 Q34315268-18C71919-027C-48A6-A550-F99A65E4D2FC Q34319242-CEA5E6CD-3225-4B16-B856-EFCEEEDD00FE Q34420014-7182D0C1-D1CD-4CEB-9218-79F988C99CC4 Q34577224-C4835330-727A-47E0-A2BE-98FD8809C4E9 Q34612492-BC38F70D-0C52-410D-A2EB-63D64850B7B9 Q34807629-BDD78B60-2493-4DAD-B3D4-4EEF0051DA4C Q34983582-1D8E6DC5-FA1B-48C7-92E4-C166F96F465C Q35019953-6924C549-19E3-4CBB-80A2-073C13EDAAC4 Q35035445-DC4B91FF-A18C-492F-9AF0-D4BEFD0C9A05 Q35068765-451340A2-7410-4D94-8D4B-6F11FF092833 Q35071491-5C0CC1C1-3D35-40EF-AD3E-EB2DE59D62B8 Q35968796-31B5F35A-9D62-4D4C-BE65-FA8DE01F79B8 Q36012138-987DFC36-0900-4063-8A6A-3C705367A3D5 Q36069532-602731ED-F63A-4BA0-BFB7-73E5AFF4A371 Q36099354-C15ADADC-0196-4A87-B29A-8675C280CF5C

P2860

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

http://www.wikidata.org/entity/Q37321697

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Benefits and risks of postmeno ...... nitiated soon after menopause.

@en

Benefits and risks of postmeno ...... nitiated soon after menopause.

@nl

type

label

Benefits and risks of postmeno ...... nitiated soon after menopause.

@en

Benefits and risks of postmeno ...... nitiated soon after menopause.

@nl

prefLabel

Benefits and risks of postmeno ...... nitiated soon after menopause.

@en

Benefits and risks of postmeno ...... nitiated soon after menopause.

@nl

P1433

Q37321697-8D8963DB-199F-49CC-B4E8-CC0C601D553A

P1476

Q37321697-8C6AE91E-3C75-45F9-9436-39F363238CAB

P2093

Q37321697-08EE9327-DB30-4387-AA41-EC74C46B4607

Q37321697-0E7CE67B-F64F-4D5C-A508-72A1AAB3E78A

Q37321697-1AF104A5-6AE1-4625-889D-A8983C28ED12

Q37321697-22300F20-E979-44E5-8165-776EAFB391BE

Q37321697-2A6AC4A3-48FB-4EF1-8C31-4EE20E8A7016

Q37321697-35D3CB6F-6140-40BC-A7C2-8FF0C76B3C96

Q37321697-8131C66F-6018-44FC-A051-5F7A54F4A98F

Q37321697-8F50448F-A36C-4A5E-84B1-3143A346071D

Q37321697-B774018A-3BC2-4608-B30C-DBB6A0A334F7

Q37321697-ED765938-B42E-47AE-B867-C17E51FCD380

P2860

Q37321697-04D141EF-E42C-4B08-A00D-CA121B062E4D

Q37321697-1AA69BE9-872F-424F-B2D2-5FAD5F28925B

Q37321697-1B60A5F0-96B1-4644-9729-DB327824F365

Q37321697-234541C6-0E8B-4E52-B6ED-57EA215B0566

Q37321697-2834C7C7-FEE4-4A25-82A7-4067EDAC899E

Q37321697-402E5959-1877-4433-86D1-823D6779C0E4

Q37321697-45C666DC-BA3C-487E-B98E-6728796D4D6E

Q37321697-4E80EE69-A8E3-46E1-BA49-E979C7A9CD3A

Q37321697-57609893-A305-4607-B043-7A2D3EBB1B73

Q37321697-58532B4A-568B-4A6E-97F0-799271C136A0

P304

Q37321697-B40A6162-6234-49E1-843B-12B0A5268D8A

P31

Q37321697-50B5523A-5FE7-4820-8CE1-9717E0589A5A

P356

Q37321697-0459EAEF-0A95-47D2-9FAD-D7BC7A3A1306

P407

Q37321697-1168263D-2DE8-43D0-A5C0-9CB4A9676EA8

P433

Q37321697-9A1BAB99-4C40-48A5-BB4C-2973A3EA2812

P478

Q37321697-FCEDE736-E7A4-4B0B-ABAB-337BAAA6DA9D

P50

Q37321697-15986782-4398-c51c-dd6d-e2ed2747b1d5

Q37321697-5C78D612-6F2D-4A5E-A9A3-DA92770355EE

Q37321697-EBF96042-513D-43BC-B1F7-4F9082E26D61

Q37321697-F3F4C707-B3A1-4524-95D5-BCC88E7B9738

Q37321697-e7bf25d5-4174-1024-1df3-371c0498e802

P577

Q37321697-DF1F57B5-76DC-46ED-8464-4B90DA4A2B12

P5875

Q37321697-A661CF01-084F-4100-B5B1-E465FAD7A661

P698

Q37321697-7E0B03A1-2FA7-435E-9073-974C8154E062

P932

Q37321697-8B8A06EB-F6FC-41AE-A1E0-8C877841F2DC

P356

P1433

American Journal of Epidemiology

P1476

Benefits and risks of postmeno ...... nitiated soon after menopause.

@en

P2093

Dorothy S Lane

http://www.w3.org/2001/XMLSchema#string

Garnet L Anderson

http://www.w3.org/2001/XMLSchema#string

Gloria Sarto

http://www.w3.org/2001/XMLSchema#string

Jacques E Rossouw

http://www.w3.org/2001/XMLSchema#string

Joann E Manson

http://www.w3.org/2001/XMLSchema#string

Judith Ockene

http://www.w3.org/2001/XMLSchema#string

Karen C Johnson

http://www.w3.org/2001/XMLSchema#string

Mary Pettinger

http://www.w3.org/2001/XMLSchema#string

Rebecca D Jackson

http://www.w3.org/2001/XMLSchema#string

Robert Brzyski

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Estrogen plus progestin and the risk of coronary heart disease.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

P304

12-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWP115

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Jean Wactawski-Wende

Matthew Allison

Robert D. Langer

Rebecca D. Jackson

P577

2009-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26239614

http://www.w3.org/2001/XMLSchema#string

P698

19468079

http://www.w3.org/2001/XMLSchema#string

P932

2733042

http://www.w3.org/2001/XMLSchema#string